Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Neoplasms, Plasma Cell × defibrotide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms, Plasma Cell 1 Multiple Myeloma 1

Interventions

Melphalan 16 Dexamethasone 11 Peripheral Blood Stem Cell Transplantation 9 Bortezomib 9 fludarabine phosphate 7 Lenalidomide 6 Calcium Dobesilate 6 Busulfan 5 pomalidomide 4 fludarabine 4 carfilzomib 4 Radiotherapy 4 Prednisone 4 liposomal doxorubicin 3 Tacrolimus 3 Mycophenolic Acid 3 Methotrexate 3 Filgrastim 3 Cyclosporine 3 Cyclophosphamide 3 Arsenic Trioxide 3 Alemtuzumab 3 samarium Sm-153 lexidronam 2 holmium-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetrakis(methylenephosphonic acid) 2 daratumumab 2 Whole-Body Irradiation 2 Pneumococcal Vaccines 2 Granulocyte Colony-Stimulating Factor 2 Bendamustine Hydrochloride 2 Ascorbic Acid 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00406978 2016-05-10

MPTD

University of Turin, Italy

Phase 1/2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡